BioSpace News Archive

On November 15, 2019, Alimera’s common stock will begin trading on a post-reverse stock split basis on The Nasdaq Global Market under the existing symbol “ALIM.”

The transaction includes RTI’s participation in a $27 million Series B funding round, which includes new investors ATW Partners and SJF Ventures along with existing investors of Health Catalyst Capital, Inova Health Systems and ARUP Laboratories.

Company is planning for end-of-Phase II meetings with regulatory authorities to discuss path forward for Phase III pivotal trials

The Medtronic 2019 Integrated Performance Report Shares Progress on Pay Equity, Diversity in Management Roles, Access to Healthcare, Environmental Performance, UN Sustainable Development Goals, and More

Applied Biomimetic, a leader in the convergence of polymer and protein membrane technologies, hosted a Grand Opening of its new production facility in Gaithersburg, Maryland on November 6th

Committed to creating tailored solutions to improve surgical outcomes, Paragon 28® has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefitting both the surgeon and patient.

Presentation to Focus on the Company’s MVA-VLP Platform for Safe and Effective Vaccines for Infectious Diseases and Cancer

Lexicon Pharmaceuticals, Inc. announced that Lonnel Coats, President and Chief Executive Officer, will present at the following conference

FUJIFILM Diosynth Biotechnologies will be expanding its gene therapy process and analytical development capabilities with the addition of new dedicated laboratories [14-November-2019] COLLEGE STATION, Texas , Nov. 14, 2019 /PRNewswire/ -- FUJIFILM Diosynth Biotechnologies (FDB), a leading global biologics Contract Development and Manufacturing Organization (CDMO) has

Other Company Research Demonstrates the Value of Diagnostic Insights in Early Cardiovascular Disease Detection in Clinical and Workplace Settings